ABBV $87.84 0.89 (1.0%)

    ABBV Profile

    ABBV trades on the NYSE.

    MEMBERSHIP
    S&P 500 Dividend Aristocrats
    SECTOR
    Health Care
    MARKET CAPITALIZATION

    $130 Billion

    Large-Cap
    TWITTER

    abbvie

    AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013. The recent announced acquisition of Allergan will add several new drugs in aesthetics and women's health.

    ABBV Earnings

    EPS

    1.27

    P/E

    22.14

    Q2 Earnings for Apr, May & Jun

    Fri, Jul 26, 2019

    Since Earnings Report

    ABBV +31.8%

    Q3 Earnings for Jul, Aug & Sep

    Fri, Nov 1, 2019

    Since Earnings Report

    ABBV +10.4%

    ABBV Dividend

    Dividend Yield

    5.37%

    Dividend Rate

    $4.72

    Ex-Dividend Date

    Tue, Jan 14, 2020

    Dividend Pay Date

    Fri, Feb 14, 2020

    Dividend Frequency

    Quarterly

    Dividend Payments

    403 Payments

    ABBV Charts

    52WL $62.66
    52WH $92.99
    All-Time $125.86


    ABBV Industry Competitors


    BIOTECH & PHARMA
    Johnson & Johnson
    Merck
    Pfizer
    Bristol-Myers Squibb
    Amgen
    Novo Nordisk A/S
    Eli Lilly
    Sanofi SA (ADR)
    Gilead Sciences
    Celgene



    Symbol MC DY Price Day YTD
    ABBV $129.86 5.37% $87.84 -1.0% -1.6%






        TOP    




    info@symbolsurfing.com


    Symbol Surfing

    ©2019 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy